Browse resources
Topic: Immunization financing
Total results with these characteristics: 73
- Advance Market Commitments
This website is a resource on Advance Market Commitments (AMC), an innovative finacing mechanism, as well as the pilot AMC for pneumococcal disease. The website contains information on what is an AMC and how manufacturers can particpate in …
Author: GAVI Alliance and The World Bank
Published: 2007
- Advance Market Commitments for Vaccines
This informative fact sheet provides a definition of Advance Market Commitments as a potential financing mechanism for bringing new vaccines to the developing world and also outlines World Health Organization's position on the mechanism.
Author: World Health Organization
Published: 2006
- Advanced Immunization Management e-Learning Module: Immunization Financing
The Advanced Immunization Management e-Learning tool is designed to provide comprehensive information to support immunization program managers at all stages of country-level decision-making. This module is designed to teach senior immunization …
Author: PATH
Published: 2009
- Advanced Immunization Management e-Learning Module: Rotavirus
The Advanced Immunization Management e-Learning tool is designed to provide comprehensive information to support immunization program managers at all stages of country-level decision-making. This module on rotavirus provides training on topics …
Author: PATH
Published: 2009
- Advanced Immunization Management e-Learning Website
Developed by PATH and Stanford University, the Advanced Immunization Management (AIM) e-Learning tool is designed to provide comprehensive information to support immunization program managers at all stages of country-level decision-making. The …
Author: PATH
Published: 2009
- Andhra Pradesh: Building a Model Immunization System
This report discusses the work of PATH's Children's Vaccine Program and the Indian state of Andhra Pradesh to build a model immunization program, including the incorporation of hepatitis B vaccine into the childhood vaccination program.
Author: PATH
Published: 2004
- The Burden of Pneumococcal Disease and Cost-Effectiveness of a Pneumococcal Vaccine in Latin America and the Caribbean: A Review of the Evidence and a Preliminary Economic Analysis
This report estimates the burden and costs of pneumococcal disease in Latin America and the Caribbean in order to inform national health authorities about disease burden and the economic value of implementing a pneumococcal …
Author: Sabin Vaccine Institute
Published: 2007
- Cambodia: "Coverage Improvement Planning" Pays Off
This report discusses the work of PATH's Children's Vaccine Program and the Australian International Health Institute of the University of Melbourne to provide technical assistance with immunization programming to Cambodia, including the …
Author: PATH
Published: 2004
- Case Study on the Costs and Financing of Immunization Services in Morocco
Partners in Health for Reform Plus, in collaboration with WHO and the Morrocan Ministry of Health, conducted an in-depth study of the costs and financing of immunization, and their report offers options in the areas of program planning, management, …
Author: Kaddar M, Mookherji S, DeRoeck D, Antona D
Published: 1999
- Case Study on the Costs of Financing of Immunization Services in Ghana
This study estimates the current and future costs of Ghana's immunization program, including the additional costs proposed for improvements to the program, both to assist planning and to inform the international community about global immunization …
Author: Levin A, England S, Jorissen J, Garshong B, Teprey J
Published: 2001
- Cost Effectiveness of Rotavirus Vaccines and Other Interventions for Diarrhoeal Diseases: Meeting Report 2006
This report from the WHO's Weekly Epidemiologic Record summarizes a meeting convened by PATH, WHO, and the US Centers for Disease Control and Prevention (CDC) on the economic burden of rotavirus disease and cost-effectiveness of vaccines. The …
Author: World Health Organization
Published: 2006
- The Cost of Immunization Programs in the Next 10 Years
This paper summarizes the results of a WHO/UNICEF study on the potential impact of immunization over the next decade and the financing required for immunization activities in the 72 poorest countries of the world.
Author: World Health Organization
Published: 2006
- Cost-Effectiveness Analysis of a Rotavirus Immunization Program for the United States
This review, published in the Journal of the American Medical Association, analyzed the cost-effectiveness of rotavirus vaccine introduction from the perspective of health care systems and society.
Author: Tucker A, Haddix A, Bresee J, et al.
Published: 1998
- A Cost-Effectiveness Analysis of Strategies for Controlling Japanese Encephalitis in Andhra Pradesh, India
Published in the Journal of Pharmaceutical Finance, Economics & Policy, this article evaluates the potential use of vaccines against Japanese encephalitis (JE) and estimates the cost-effectiveness of mass vaccination campaigns and routine …
Author: Suraratdecha C, Jacobson J, Sivalenka S, Narahari D
Published: 2006
- Cost-Effectiveness and Potential Impact of Rotavirus Vaccination in the United States
This study, published in the journal Pediatrics, examines the costs and benefits of routine rotavirus vaccination for infants in the US, using a hypothetical cohort of unvaccinated infants. Researchers determined that, at current prices, …
Author: Widdowson MA, Meltzer MI, Zhang X, et al.
Published: 2007
- Cost-Effectiveness of Introducing a Rotavirus Vaccine in Developing Countries: The Case of Mexico
This study, published in BMC Infectious Diseases, developed a model to compare the cost and disease burden of rotavirus in unvaccinated children in Mexico. The study determined that it would be highly cost-effective to include rotavirus vaccine …
Author: Valencia-Mendoza A, Bertozzi SM, Gutierrez JP, Itzler R
Published: 2008
- Cost-Effectiveness of Rotavirus Vaccines
This article, published in Expert Review Pharmacoeconomics Outcomes Research, reviews economic evaluations of Rotarix® and RotaTeq® and offers suggestions for future analyses of cost-effectiveness. ABSTRACT ONLY. (Learn how users in …
Author: Walker D, Rheingans R
Published: 2005
- Cost-Effectiveness of Routine Immunization to Control Japanese Encephalitis in Shanghai, China
From the Bulletin of the World Health Organization, this article investigates the cost-effectiveness of JE immunization in China and demonstrates that a JE immunization program can be a cost-saving intervention for countries.
Author: Ding D, Kilgore PE, Clemens JD, Liu W, Xu Z
Published: 2003
- Costs of Community-Acquired Pediatric Rotavirus Gastroenteritis in 7 European Countries: The REVEAL Study
Investigators found that rotavirus gastroenteritis incurs considerable use of health care resources and results in substantial costs for families of patients and employers. Routine rotavirus vaccination could significantly reduce the related …
Author: Giaquinto C, Van Damme P, Huet F, Gothefors L, Van der Wielen M
Published: 2007
- Developing Country Manufacturers and Sustainability of Vaccine Supply
This paper outlines the role of developing country vaccine manufacturers in global efforts to increase access to vaccines.
Author: World Health Organization
Published: 2006
- Disease Control Priorities in Developing Countries, Second Edition
A comprehensive global health examination, Disease Control Priorities in Developing Countries contributes substantially to global initiatives to improve the health of all peoples by providing a multidisciplinary understanding of fundamental …
Author: Disease Control Priorities Project
Published: 2008
- Dispensing Hope: Bill Gates' Global Health Gamble
This fascinating special report focuses on the immunization and health-related initiatives supported by the Bill & Melinda Gates Foundation and the reasons for choosing these programs.
Author: Paulson T
Published: 2001
- Draft Regional Framework for Decision-Making on the Introduction of Malaria Vaccines in Sub-Saharan African Countries
This framework serves as a guide for planning for and conducting global and national decision-making on the introduction of a future malaria vaccine. The document also describes processes and activities that led to the development of …
Author: PATH, World Health Organization
Published: 2006
- Economic Evaluation of Delivering Haemophilus influenzae type b Vaccine in Routine Immunization Services in Kenya
This study, published in Bulletin of the World Health Organization, discusses the introduction of Hib vaccine in Kenya, one of the first nine countries to receive financial support from GAVI for Hib vaccine introduction. The objective of this study …
Author: Oloo Akumu A, Englisha M, Scott JAG, Griffiths UK
Published: 2007
- Economic Evaluation of Haemophilus influenzae type b Vaccination in Indonesia: A Cost-Effectiveness Analysis
This paper, published in the Journal of Public Health, evaluates the cost-effectiveness of introducing Hib vaccine in Indonesia as an addition to the country's current DTP–Hepatitis B vaccination program.
Author: Broughton E
Published: 2007

